Form 8-K - Current report:
SEC Accession No. 0001628280-25-028529
Filing Date
2025-05-30
Accepted
2025-05-30 13:46:41
Documents
15
Period of Report
2025-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20250530.htm   iXBRL 8-K 25643
2 EX-99.1 a8k2025-05x30abclexhibit.htm EX-99.1 5955
6 a8k2025-05x30abclexhibit001.jpg GRAPHIC 240670
7 a8k2025-05x30abclexhibit002.jpg GRAPHIC 159269
  Complete submission text file 0001628280-25-028529.txt   695942

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20250530.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20250530_lab.xml EX-101.LAB 20678
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20250530_pre.xml EX-101.PRE 11962
18 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20250530_htm.xml XML 2593
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 251009558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)